insights_auto
Why is I5X up 4.04%?
Dive Deeperchevron_right
I5X:FRA
Precigen Inc
€6.70
arrow_upward
+4.04%(+0.26) 1D
Sep 25, 10:00:00 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for I5X...
Open
€6.70
High
€6.70
Low
€6.70
Mkt. cap
2.77B
Avg. vol.
42.00
Volume
0.00
52-wk high
€6.90
52-wk low
€2.60
No. of employees
160
Open
€6.70
High
€6.70
Low
€6.70
Mkt. cap
2.77B
Avg. vol.
42.00
Volume
0.00
52-wk high
€6.90
52-wk low
€2.60
No. of employees
160
News stories
From web sources and news partners
Stocktwits
·
1 day ago
MRNA, PGEN Stocks Hit Multi-Year Highs – What’s Driving The Momentum Today?
Investing.com
·
2 days ago
Precigen stock hits 52-week high at 8.05 USD
TipRanks
·
2 days ago
Precigen Stock Slips As Wall Street Turns Bullish
Investing.com
·
2 days ago
B.Riley initiates Precigen stock coverage with buy on drug launch
Profile
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
About Precigen Inc
CEOHelen Sabzevari
Employees160
FoundedMay 21, 1998
Headquarters-
SectorBiotechnology
Websiteprecigen.com